<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02393430</url>
  </required_header>
  <id_info>
    <org_study_id>GH 0123</org_study_id>
    <nct_id>NCT02393430</nct_id>
  </id_info>
  <brief_title>Clinical Effect of Rebamipide on Chronic Gastritis</brief_title>
  <official_title>Clinical Effect of Rebamipide on Chronic Gastritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BangMao Wang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tianjin Medical University General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the clinical effect of rebamipide in chronic gastritis patients. Patients with
      chronic gastritis were randomly divided into the experimental group and the control group.
      The experimental group were treated with rebamipide 0.1g tid and optimization of life style,
      and the control group were only optimized their life style for 26 weeks. Upper
      gastrointestinal endoscopy was performed in all patients to evaluate the severity of
      gastritis by modified Lanza score (MLS) and the histology by the updated Sydney system before
      and after treatment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>modified Lanza score</measure>
    <time_frame>26 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>visual Analog scale</measure>
    <time_frame>26 weeks</time_frame>
    <description>to describe the inflamamtory of gastric mucosa pathologically</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Gastritis</condition>
  <arm_group>
    <arm_group_label>experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental group were treated with rebamipide 0.1g tid and optimization of life style.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The control group were only optimized their life style.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rebamipide</intervention_name>
    <description>Rebamipide is a</description>
    <arm_group_label>experimental</arm_group_label>
    <other_name>Mucosta</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>optimization of life style</intervention_name>
    <arm_group_label>experimental</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  With the symptoms as follow: epigastric pain, abdominal discomfort, abdominal
             distention, poor appetite, nausea, vomiting and so on

          -  diagnosed as chronic gastritis with endoscopic and pathological methods

          -  agree to join in this clinical trail

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wang Bang-mao</last_name>
    <role>Study Chair</role>
    <affiliation>Tianjin meidcal university general hospital,China</affiliation>
  </overall_official>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2014</study_first_submitted>
  <study_first_submitted_qc>March 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2015</study_first_posted>
  <last_update_submitted>March 15, 2015</last_update_submitted>
  <last_update_submitted_qc>March 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Tianjin Medical University General Hospital</investigator_affiliation>
    <investigator_full_name>BangMao Wang</investigator_full_name>
    <investigator_title>Chief of Gastroenterology Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rebamipide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

